ZILBRYSQ ZILUCOPLAN Trademark

Trademark Overview


On Friday, May 15, 2020, a trademark application was filed for ZILBRYSQ ZILUCOPLAN with the United States Patent and Trademark Office. The USPTO has given the ZILBRYSQ ZILUCOPLAN trademark a serial number of 88918443. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 28, 2021. This trademark is owned by Ra Pharmaceuticals, Inc.. The ZILBRYSQ ZILUCOPLAN trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or an...

Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication
zilbrysq zilucoplan

General Information


Serial Number88918443
Word MarkZILBRYSQ ZILUCOPLAN
Filing DateFriday, May 15, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 28, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 29, 2020

Trademark Statements


Indication of Colors claimedThe colors gray, blue, orange, and red are claimed as features of the mark.
Disclaimer with Predetermined Text"ZILUCOPLAN"
Description of MarkThe mark consists of the word "ZILUCOPLAN" in gray under the word "ZILBRYSQ", where the letters "ZILBRYS" of "ZILBRYSQ" are in a blue font and letter "Q" fades from orange to red to blue in a clockwise direction starting from the bottom of the "Q" and ending at the tail of the "Q".
Goods and ServicesPharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents, all of the foregoing containing Zilucoplan
Goods and ServicesSyringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication
Translation of Words in MarkThe wording "ZILBRYSQ ZILUCOPLAN" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, May 30, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRa Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Party NameRa Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Monday, June 28, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 28, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 24, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 29, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 29, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 9, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 25, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 25, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, August 25, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 25, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, August 25, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, August 24, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, August 19, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 4, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 4, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, August 4, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 4, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, August 4, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 22, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, July 8, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 22, 2020ASSIGNED TO LIE
Thursday, June 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 18, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, June 18, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 18, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, June 18, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, June 18, 2020ASSIGNED TO EXAMINER
Saturday, May 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 19, 2020NEW APPLICATION ENTERED IN TRAM